Nervionoix Pro Neuropathy Fast Acting Cream
NDC Package 87752-002-01
Package Information
Nervionoix Pro Neuropathy Fast Acting Cream (lidocaine hydrochloride, menthol, magnesium chloride) cream is adults and children 12 years of age and older: Apply to affected area not more than 3 to 4 times daily.Children under 12 years of age: Consult a doctor before use.We recommend testing a small amount of cream on your skin first to check for skin reaction and comfort level; wait 15 minutes before applying to affected area if you are happy with the comfort level. This formulation utilizes a cream delivery system. Marketed by Micelle Laboratories, Incorporated, this product is identified by NDC 87752-002.
Identification & Billing
Clinical Specifications
- Amide Local Anesthetic - [EPC] (Established Pharmacologic Class)
- Amides - [CS]
- Antiarrhythmic - [EPC] (Established Pharmacologic Class)
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Local Anesthesia - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 87752 - Micelle Laboratories, Incorporated
- 87752-002 - Nervionoix Pro Neuropathy Fast Acting Cream
- 87752-002-01 - 227 g in 1 JAR
- 87752-002 - Nervionoix Pro Neuropathy Fast Acting Cream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (87752-002). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87752-002-01 identifies a specific commercial package of 227 g in 1 jar of Nervionoix Pro Neuropathy Fast Acting Cream, a human over the counter drug labeled by Micelle Laboratories, Incorporated. This cream is formulated for topical use and contains lidocaine hydrochloride; magnesium chloride; menthol as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Micelle Laboratories, Incorporated on June 03, 2026. The current certification is valid through December 31, 2027.
How is this Micelle Laboratories, Incorporated product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87752000201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.
